Kidney Research and Clinical Practice

Search

Page Path

Efficacy and cost-effectiveness of darbepoetin alfa once every 4 weeks versus continuous erythropoietin receptor activator once every 4 weeks for anemia correction in patients with chronic kidney disease not on dialysis: Geo Neul Park, Kyung Ho Lee, Ji Eun Moon et al.; Kidney Res Clin Pract. 2024;43(3):369-380. Published online January 23, 2024; DOI: https://doi.org/10.23876/j.krcp.23.074; Full text PubReader ePub PDF Supplementary Material

Comparison of Erythropoietic Effect between Epoetin-α and Darbepoetin-α in Hemodialysis Patients: A Randomized Crossover Study: Ji Young Lee, M.D., Seung Woon Byun, M.D., Young Sun Yeo, M.D., Won Seok Yang, M.D., Su-Kil Park, M.D., Jung Sik Park, M.D. and Jai Won Chang, M.D.; Korean J Nephrol. 2009;28(5):450-455.; PDF

Kidney Research
and
Clinical Practice

Print ISSN: 2211-9132
Online ISSN: 2211-9140

MOST VIEWED MOST CITED

3,587	Unveiling the enigma of acute kidney disease: predicting prognosis, exploring interventions, and embracing a multidisciplinary approach
3,024	Biomarkers in pursuit of precision medicine for acute kidney injury: hard to get rid of customs
7,652	Genetic variants of interferon lambda-related genes and chronic kidney disease susceptibility in the Korean population
11,934	How should we treat acute kidney injury caused by renal congestion?
2,905	Personalized nutritional management in the transition from non-dialysis dependent chronic kidney disease to dialysis

Cited By 33	GLP-1 receptor agonists in diabetic kidney disease: current evidence and future directions
Cited By 22	Association between blood pressure and the risk of chronic kidney disease in treatment-naïve hypertensive patients
Cited By 19	Uremic pruritus: pathophysiology, clinical presentation, and treatments
Cited By 17	Serum cystatin C to creatinine ratio is associated with sarcopenia in non-dialysis-dependent chronic kidney disease
Cited By 17	Deep learning predicts the differentiation of kidney organoids derived from human induced pluripotent stem cells

Editorial Office: #301, (Miseung Bldg.) 23, Apgujenog-ro 30-gil, Gangnam-gu, Seoul 06022, Korea
Tel: +82-2-3486-8736 Fax: +82-2-3486-8737 E-mail: registry@ksn.or.kr